BioSpace6h
Trump’s Whiplash Policies Keep Pharmas on Their Toes
As the Q4 2024 pharma earnings period rolls on through the first month of President Donald Trump’s second term, executives ...
RFK Jr's secret dinner with Pfizer CEO revealed
Pfizer CEO Albert Bourla told investors he dined with RFK Jr, a vaccine skeptic and nominee to head HHS. They discussed ...
Pfizer: 3 Key Risks That Warrant A Sell
Pfizer faces revenue decline from patent expirations, profitability challenges, and bearish technicals. Learn why PFE stock ...
The faulty forecasts of pharma firm investors: Misguided cynics miss the promising prognosis for drugmakers Pfizer and Merck
Pfizer and Merck, ostensibly beleaguered drugmakers, have seen their shares battered despite reporting strong earnings.
Wall Street Week: Concerns About Tariffs and Hope on Cancer
Welcome to the Wall Street Week newsletter, bringing you stories of capitalism about things you need to know, but even more ...
Zepbound sales double, tariffs could hit Ozempic, and Pfizer on RFK Jr.: Pharma news roundup
Sales of Eli Lilly’s (LLY) blockbuster weight-loss drug Zepbound doubled in the fourth quarter year over year, despite ...
pharmaphorum1d
Ex-Pfizer leaders side with firm against activist investor
Two former Pfizer executives drawn into a campaign ... saying they are "fully supportive of Pfizer chairman and CEO Albert Bourla, senior management and the board, and we are confident that ...